Melanoma Antigen Preferentially Expressed In Tumors (PRAME) Antibody (FITC)

REQUEST MORE INFO
Catalogue No: abx344183
Price: US$188.50
(Size: 20 µg)

Click on the image to see the image legend

Available Options

* Size:





Add to Shopping Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Melanoma Antigen Preferentially Expressed In Tumors (PRAME) Antibody (FITC) is a Rabbit Polyclonal antibody conjugated to FITC for the detection of Human PRAME.

Target Melanoma Antigen Preferentially Expressed In Tumors (PRAME)
Clonality Polyclonal
Reactivity Human
Host Rabbit
Recommended dilutions Optimal dilutions/concentrations should be determined by the end user.
Conjugation FITC
Excitation/Emission 499/515
Laser Line 488
Immunogen Recombinant Human Melanoma antigen preferentially expressed in tumors protein (1-509 AA)
Isotype IgG
Form Liquid
Purity > 95%
Purification Purified by Protein G chromatography.
Storage Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
UniProt Primary AC P78395 (UniProt, ExPASy)
UniProt Secondary AC B2R6Y7, O43481, Q8IXN8
UniProt Entry Name PRAME_HUMAN
Gene Symbol PRAME
GeneID 23532
OMIM 606021
HGNC 9336
KEGG hsa:23532
Ensembl ENSG00000185686
String 9606.ENSP00000445675
Buffer 0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% glycerol.
Availability Shipped within 5-10 working days.
Note THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Research Articles on Melanoma Antigen Preferentially Expressed In Tumors (PRAME)
Tags:
(Click to show)